Zobrazeno 1 - 10
of 35
pro vyhledávání: '"S. P. Chumakov"'
Autor:
R. S. Kalinin, V. M. Ukrainskaya, S. P. Chumakov, A. M. Moysenovich, V. M. Tereshchuk, D. V. Volkov, D. S. Pershin, E. G. Maksimov, H. Zhang, M. A. Maschan, Y. P. Rubtsov, A. V. Stepanov
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
CAR-T cell therapy is the most advanced way to treat therapy resistant hematologic cancers, in particular B cell lymphomas and leukemias, with high efficiency. Donor T cells equipped ex vivo with chimeric receptor recognize target tumor cells and kil
Externí odkaz:
https://doaj.org/article/7af56f3fcb4a480dab30c7f8e6f1c0c9
Publikováno v:
Медицинская иммунология, Vol 20, Iss 3, Pp 313-340 (2018)
Our understanding of anticancer immune surveillance currently serves as a basis for development of novel therapies that utilize patient’s own immune system as an anticancer agent. Previously, cancer immunotherapy mostly included non-specific immuno
Externí odkaz:
https://doaj.org/article/70bf3e70f41f401cb4a13e41f51b4853
Publikováno v:
Молекулярная биология. 54:95-102
Cancer stem cells (CSCs) are the most malignant subpopulation of tumor cells that possess a tumorigenic potential and resistantance to chemotherapy. These properties make CSCs a promising target for the development of targeted antitumor therapy which
Autor:
Michael Maschan, S. P. Chumakov, D. V. Volkov, Yury P. Rubtsov, Alexey Stepanov, A. M. Moysenovich, Eugene G. Maksimov, Dmitry Pershin, R. S. Kalinin, V. M. Tereshchuk, Hongkai Zhang, V. M. Ukrainskaya
Publikováno v:
Frontiers in Molecular Biosciences
Frontiers in Molecular Biosciences, Vol 8 (2021)
Frontiers in Molecular Biosciences, Vol 8 (2021)
CAR-T cell therapy is the most advanced way to treat therapy resistant hematologic cancers, in particular B cell lymphomas and leukemias, with high efficiency. Donor T cells equipped ex vivo with chimeric receptor recognize target tumor cells and kil
Autor:
S. P. Chumakova, O. I. Urazova, V. M. Shipulin, I. V. Sukhodolo, A. I. Stelmashenko, O. A. Denisenko, S. L. Andreev, M. S. Demin, E. G. Churina
Publikováno v:
Acta Biomedica Scientifica, Vol 8, Iss 6, Pp 81-90 (2024)
Background. In the pathogenesis of ischemic cardiomyopathy (ICMP), angiopoiesis remains unexplored.The aim. To describe the vasculature of the heart and the imbalance of angiogenesis mediators in the coronary circulation in association with the numbe
Externí odkaz:
https://doaj.org/article/4204d4b23aba4e4d9d61dda54c0f69ab
Publikováno v:
NANOMEDICINE. :155-161
Cancer immunotherapy with T-cells that carry chimeric antigen receptors is currently on cutting edge of modern oncology. Autotransplantation of T-lymphocytes with chimeric receptor specific for certain tumor antigen proves to be clinically effective,
Publikováno v:
Innate antiviral immunity.
Most triple negative breast cancers (TNBC) are characterized by elevated expression of mesothelin (MSLN), a cell surface antigen and one of the preferred targets for the therapy of solid tumors. Most continuous TNBC cell lines are MSLN-negative, whic
Autor:
Yuriy Nikolaevich Lezhnin, S. P. Chumakov, N. M. Ratnikova, J. E. Kravchenko, Elena I. Frolova
Publikováno v:
Molecular Biology. 51:216-225
Recently, a number of new highly efficient antibody-based anticancer therapeutics have emerged. These receptor-binding antibodies have beneficial toxicity profiles associated with relatively mild side effects. Therefore, the search for novel surface
Publikováno v:
Molekuliarnaia biologiia. 54(1)
Cancer stem cells (CSCs) are the most malignant subpopulation of tumor cells that possess a tumorigenic potential and resistantance to chemotherapy. These properties make CSCs a promising target for the development of targeted antitumor therapy which
Publikováno v:
Bulletin of Experimental Biology and Medicine. 164:99-101
Stable red fluorescing line of human ovarian epithelial cancer cells SK-OV-3ip-red was generated expressing gene coding for protein TurboFP635 (Katushka) fluorescing in the far-red spectrum region with excitation and emission peaks at 588 and 635 nm,